KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Net Income - Minority (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Net Income - Minority readings, the most recent being -$4.0 million for Q1 2026.

  • On a quarterly basis, Net Income - Minority rose 42.86% to -$4.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$4.0 million, a 42.86% increase, with the full-year FY2025 number at -$4.0 million, up 42.86% from a year prior.
  • Net Income - Minority hit -$4.0 million in Q1 2026 for Teva Pharmaceutical Industries, roughly flat from -$4.0 million in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of -$4.0 million in Q3 2025 to a low of -$916.0 million in Q1 2022.
  • Median Net Income - Minority over the past 5 years was -$319.0 million (2024), compared with a mean of -$393.1 million.
  • Biggest five-year swings in Net Income - Minority: rose 6.05% in 2022 and later surged 98.87% in 2024.
  • Teva Pharmaceutical Industries' Net Income - Minority stood at -$794.0 million in 2022, then increased by 21.91% to -$620.0 million in 2023, then surged by 98.87% to -$7.0 million in 2024, then soared by 42.86% to -$4.0 million in 2025, then changed by 0.0% to -$4.0 million in 2026.
  • The last three reported values for Net Income - Minority were -$4.0 million (Q1 2026), -$4.0 million (Q4 2025), and -$4.0 million (Q3 2025) per Business Quant data.